Revise clinical trial protocol for Remdesivir powder for inhalation: CDSCO panel tells Lupin Medical Dialogues Team4 Aug 2021 4:00 PM ISTNew Delhi: In response to the drug maker Lupin's proposal to conduct a PhaseII/III Clinical Trial protocol for Remdesivir Powder for Inhalation,...
Provide more safety, immunogenicity data: CDSCO panel tells Biological E on trial of COVID vaccine Medical Dialogues Team3 Aug 2021 3:50 PM ISTNew Delhi: Following the proposal presented by Biological E to conduct a Phase II/III clinical trial of its Covid-19 vaccine containing the SARSCoV-2...
Drug Safety Alert: Indian Pharmacopoeia Commission flags adverse reactions linked to Etoricoxib, others Medical Dialogues Team2 Aug 2021 6:28 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of July, has revealed that certain...
NPPA revises MRP of 1034 models of 5 medical devices used in COVID management, Details Medical Dialogues Team1 Aug 2021 11:30 AM ISTNew Delhi: In accordance with the Trade Margin Rationalization (TMR) notification for 5 Medical Devices commonly used in Covid 19 management, the...
CDSCO flags 39 drug samples including Aspirin, Remdesivir as not of standard quality Medical Dialogues Team31 July 2021 12:45 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has flagged 39...
Sun Pharma secures CDSCO panel okay for Amantadine ER Tablets to treat Parkinson Medical Dialogues Team30 July 2021 12:35 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Lupin Medical Dialogues Team29 July 2021 6:21 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin, going off-patent, the National Pharmaceutical Pricing Authority (NPPA) panel, giving...
NPPA has fixed ceiling prices of 355 medicines, 882 formulations: Minister tells Parliament Medical Dialogues Team28 July 2021 3:41 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority has fixed the ceiling prices of 355 medicines and 882 formulations for medicines under...
Withdraw marketing of Durvalumab for metastatic urothelial carcinoma: CDSCO panel tells AstraZeneca Medical Dialogues Team27 July 2021 5:43 PM ISTNew Delhi: In a major setback to AstraZeneca Pharma India Limited., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Setback to AstraZeneca: Delhi HC rejects plea against 9 pharma firms over Dapagliflozin Medical Dialogues Team26 July 2021 4:12 PM ISTNew Delhi: In a major setback to AstraZeneca and its Indian subsidiary ,the Delhi High Court has dismissed AstraZeneca's plea against nine generic...
Include more Govt sites in Dapagliflozin, Teneligliptin FDC phase 3 trial: CDSCO panel tells Macleods Pharma Medical Dialogues Team25 July 2021 11:15 AM ISTNew Delhi: Macleods Pharmaceutical has recently received permission from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
AstraZeneca gets US nod for once-weekly diabetes drug Bydureon for kids Ruchika Sharma24 July 2021 4:57 PM ISTThe drug aims to help reduce blood sugar levels along with diet and exercise.
